tirzepatide
Tirzepatide is a novel injectable medication that works by stimulating both GLP-1 and GIP receptors. This dual-action mechanism helps lower blood sugar levels, improve insulin sensitivity, and promote weight loss by curbing appetite and slowing gastric emptying.
Tirzepatide is administered via a subcutaneous injection (under the skin) once a week. The injection is typically given in the abdomen, thigh, or upper arm using a pre-filled pen for easy self-administration.
Most users begin to see improvements in blood sugar control and experience weight loss within 2–4 weeks of starting Tirzepatide, although the full effects may take a few months to fully manifest.
The most common side effects are nausea, diarrhea, vomiting, and constipation, particularly when starting the medication. These side effects typically decrease over time. Rare but serious side effects may include pancreatitis and thyroid issues, so regular check-ups are recommended.
*According to the Cleavland Journal of Medicine
starting weight:
lose up to:
Real Results, Real Confidence

Delivered To Your Door
%201.avif)

.avif)


Why Choose Ezra?

tirzepatide
BLACK BOX WARNING:
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2. Do not take them if you have ever had thyroid cancer. In studies with rodents, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans. Please notify your doctor ASAP if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
If you experience a medical emergency, call 911 or go to the nearest emergency room.
Tell your healthcare provider about your medical history prior to taking Ozempic®.
Avoid alcohol while taking this medication. If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Ozempic®, as your diabetes medications may need to be adjusted as you lose weight.
Use adequate contraception while taking this medication. Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have kidney, liver, or pancreas problems.
Stop using Ozempic® and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Ozempic® if suspected and promptly seek medical advice